Burt Wealth Advisors Acelrx Pharmaceuticals Inc Transaction History

Burt Wealth Advisors

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 Apr 15, 2021	SELL	$1.25 - $2.77 $1,250 - $2,770	-1,000 Closed	0 $0
Q2 2018 Jul 27, 2018	BUY	$2.13 - $4.2 $2,130 - $4,200	1,000 New	1,000 $3,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Burt Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Burt Wealth Advisors with notifications on news.